Skip to main content

Table 5 Mean ADC values in patients evaluated by RECIST 1.1, m RECIST, and tumor volume

From: Diffusion-weighted MR imaging diagnostic merits in the post-therapeutic assessment of musculoskeletal soft tissue sarcoma

RECIST 1.1 Mean ADC value m RECIST Mean ADC value Tumor volume (VOL) Mean ADC value
Increased in tumor longest dimension (18/36) 12/18 (67%) had decrease in mean ADC values Increased tumor enhancing component (15/36) 11/15 (73.3%) showed decreased mean ADC values Increased tumor volume (17/36) Reduction of mean ADC value in 11/17 (64.7%)
6/18 (33%) of patients had increase in mean ADC values 4/15 (26.7%) showed increased mean ADC values 6/17 (35.3%) increase in the mean ADC value
No change in tumor size (1/36) Increase in mean ADC value No change in enhancing tumor size (1/36) Increased mean ADC value No change in enhancing tumor volume (1/36) Increased mean ADC value
Decrease in tumor longest dimension (17/36) 16/17 (94%) of patients showed increased mean ADC values Decreased enhancing tumor sizes (20/36) 18/20 (90%) of patients showed increase in mean ADC values Decreased enhancing tumor volume (18/36) 16/18 (88.8%) showed increase in mean ADC values
1/17 (6%) showed decreased mean ADC value. 2/20 (10%) showed decrease in mean ADC values   2/18(11.2%) showed decrease in mean ADC values